Mots-c 20 mg is a high-quality Mitochondrial-Derived Peptide (MDP) independently developed and produced by BLOOM TECH, with the corresponding CAS No. 1627580-64-6 and a purity of up to 98% (HPLC standard). It is provided at reagent grade to precisely meet the demands of scientific research and related application scenarios.The main ingredient is human-derived MOTS-c, consisting of 16 amino acids, and is refined using advanced peptide synthesis technology. Impurity content and activity retention are strictly controlled during production. Each box has a standardized specification of 20 mg, and the packaging is designed for both sealing performance and convenience, effectively ensuring product stability during storage and transportation.With reliable quality and stable performance, it has become one of the core peptide products of BLOOM TECH and is widely recognized and trusted by customers worldwide.
|
|
|
|
|
|
|
|
Cooperation Overview: Purchase Details from a Long-Term UK Client
The client in this cooperation is a long-term UK partner of BLOOM TECH. Based on a long-term and stable cooperative foundation, efficient and smooth communication, and BLOOM TECH's consistent commitment to quality, a profound partnership has been established.
The client has long been engaged in peptide-related scientific research and applications, with extremely high requirements for product purity, specification accuracy, and supply stability. According to its business needs, the client placed a bulk order covering multiple core peptide products, with details as follows:
3 boxes of Retatrutide 10 mg at USD 180 per box
2 boxes of Mots-c(https://en.wikipedia.org/wiki/MOTS-c) 20 mg at USD 185 per box
1 box of CJC 1295 without DAC 10 mg at USD 200 per box
1 box of Ipamorelin 10 mg at USD 103 per box
1 box of Retatrutide 20 mg at USD 250 per box
1 box of Cagrilintide 5 mg at USD 158
Total shipping fee for 9 boxes: USD 85Total order value: USD 1706
Upon receiving the order, BLOOM TECH responded promptly, verified product specifications, quantities, and delivery time in strict accordance with customer requirements, efficiently completed the whole process of stock preparation, testing, and packaging, accurately matched customer needs, and successfully fulfilled the order, further consolidating the long-term cooperative relationship between both parties.
Core Product Analysis: Applications of Mots-c 20 mg
As one of the core products in this order, Mots-c 20 mg has become a key category for customer procurement due to its unique pharmacological activity and wide application scenarios. Its applications are mainly focused on scientific research and potential uses in related fields, including metabolic regulation, cytoprotection, anti-aging, cardiovascular health, neuroprotection, and exercise performance improvement. It is a highly versatile and valuable reagent in peptide research.
In the field of metabolic regulation, Mots-c 20 mg can effectively activate the AMP-activated protein kinase (AMPK) signaling pathway by promoting the biosynthesis of the endogenous AMP analog AICAR. As a core regulator of cellular energy metabolism, this pathway effectively balances cellular glucose and lipid metabolism. It can significantly improve cellular glucose uptake efficiency and insulin resistance, providing important reagent support for research on the pathogenesis and potential therapeutic targets of metabolic diseases such as type 2 diabetes and obesity. It also inhibits adipocyte differentiation and lipid accumulation, offering a reliable material basis for weight-loss-related pharmacological research and functional reagent development.
In the fields of cytoprotection and anti-inflammation, Mots-c 20 mg shows excellent activity advantages. In vitro cell experiments and animal studies have confirmed that when cells are exposed to adverse conditions such as oxidative stress, nutrient deficiency, or toxin stimulation, the product can rapidly translocate into the nucleus and regulate the expression of various nuclear genes. By inhibiting the over-activation of the mitogen-activated protein kinase/nuclear factor-κB (MAPK/NF-κB) pathway, it significantly reduces the secretion of inflammatory factors including TNF-α and IL-6, and alleviates cell damage caused by inflammation. Meanwhile, it enhances the activity of intracellular antioxidants such as superoxide dismutase (SOD) and glutathione (GSH), scavenges excessive free radicals, reduces oxidative damage to cellular DNA and mitochondria, and delays apoptosis. It can be widely used in research on cytoprotective mechanisms, anti-inflammatory drug screening, and antioxidant reagent development, especially for studies on vulnerable cells such as liver and kidney cells.
In the field of cardiovascular health, the application value of Mots-c 20 mg is particularly prominent. It protects vascular endothelial integrity and prevents the occurrence and development of atherosclerosis by inhibiting inflammation and oxidative damage in vascular endothelial cells. It also regulates energy metabolism in cardiomyocytes, enhances myocardial contractility, reduces myocardial ischemia-reperfusion injury, and prevents cardiac remodeling, providing strong support for basic research, pathological mechanism exploration, and potential drug development for cardiovascular diseases such as hypertension, coronary heart disease, and heart failure. It is a commonly used core reagent in cardiovascular peptide research.
In addition, Mots-c 20 mg is closely related to the aging process. Its endogenous activity gradually declines with age, and exogenous supplementation can effectively improve aging-related metabolic disorders and reduced cell viability, providing important references for research on age-related diseases such as Alzheimer's disease and osteoporosis, as well as the mechanism of lifespan regulation. In neuroprotection, it protects neuronal integrity by regulating neural cell metabolism and inhibiting neuroinflammation, supporting research on neurodegenerative diseases such as Parkinson's disease and Alzheimer's disease. In exercise performance research, it improves muscle cell energy supply and enhances muscle endurance, assisting studies in exercise physiology and sports medicine.
The long-term UK client is deeply engaged in peptide research, and the procurement of Mots-c 20 mg is for multiple research projects related to metabolic regulation and cytoprotection, which fully reflects the product's versatile applications and core value.
Market Prospect: Development Potential of Mots-c 20 mg
With increasing global investment in peptide research and continuous in-depth studies in metabolic diseases, anti-aging, cardiovascular health and other fields, the market demand for Mots-c 20 mg shows a steady upward trend with broad development prospects.
Against the background of the continuous expansion of the global peptide drug and research reagent market, mitochondrial-derived peptides, as a new type of active peptide, have gradually attracted attention from the scientific and industrial communities for their unique physiological functions and application potential. The continuous emergence of relevant research results provides a solid theoretical and technical foundation for the application expansion of Mots-c 20 mg.
In terms of market demand, demand for high-quality Mots-c products is rising among research institutions, pharmaceutical enterprises, and health-related application explorers, especially in regions with advanced scientific research such as Europe and the United States. The bulk purchase from the long-term UK client fully confirms the product's recognition in overseas markets.
Cooperation Summary and Future Outlook
As a professional R&D, manufacturer and supplier of peptide products, BLOOM TECH always takes quality as the core and customer needs as the orientation. We continuously optimize the production process of Mots-c 20 mg and other products to improve product quality and performance, while constantly improving the supply chain system to ensure stable supply and timely delivery.
The successful cooperation with the long-term UK client is not only a high recognition of the quality of Mots-c 20 mg, but also a full affirmation of BLOOM TECH's service level and supply capacity.
In the future, BLOOM TECH will continue to deepen the peptide field, focus on technological innovation and application expansion of core products such as Mots-c 20 mg, and continuously enhance product competitiveness. Relying on a sound global service network, we will provide global customers with higher-quality products and more efficient services, support the sustainable development of peptide research and industry, and look forward to win-win cooperation with more new and existing customers to create a new future for the industry.
